Changes in Mannose-Binding Lectin and Collectin Kidney 1 Levels in Sepsis Patients With and Without Disseminated Intravascular Coagulation.


Journal

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
ISSN: 1938-2723
Titre abrégé: Clin Appl Thromb Hemost
Pays: United States
ID NLM: 9508125

Informations de publication

Date de publication:
Historique:
entrez: 28 2 2019
pubmed: 28 2 2019
medline: 6 6 2019
Statut: ppublish

Résumé

In sepsis, systemic coagulation activation frequently causes disseminated intravascular coagulation (DIC), and the uncontrolled activation of the complement system can induce multiple organ dysfunction and poor prognosis. This study aimed to examine the association of DIC with levels of collectin kidney 1 (CL-K1), a novel collectin of the complement system, and mannose-binding lectin (MBL), a classical-type collectin in patients with sepsis. We collected blood samples prospectively from adult patients with sepsis admitted to the intensive care unit (ICU) from day 1 (admission) to day 5. The CL-K1 and MBL levels were measured by enzyme-linked immunosorbent assay, and DIC was diagnosed by using a scoring algorithm. The correlation of CL-K1 and MBL levels with other coagulation markers was analyzed. There were 37 patients with DIC (DIC group) and 15 without DIC (non-DIC group). Compared to the non-DIC group, the DIC group had more severe conditions and higher mortality. During the 5 days after ICU admission, plasma CL-K1 levels were similar between the groups, but plasma MBL levels were significantly lower in the DIC group. Plasma CL-K1 levels were weakly correlated with prothrombin time, activated partial thromboplastin time, and antithrombin levels; plasma MBL levels were weakly correlated with fibrin/fibrinogen degradation product levels and DIC score. In conclusion, during the first 5 days of ICU admission, plasma CL-K1 levels were similar between the DIC and non-DIC groups. However, plasma MBL levels were lower in the DIC group compared to the non-DIC group, and the significance of this difference grew gradually over time.

Identifiants

pubmed: 30808212
doi: 10.1177/1076029618821189
pmc: PMC6714923
doi:

Substances chimiques

Biomarkers 0
Collectins 0
Mannose-Binding Lectin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1076029618821189

Références

Liver. 2002 Feb;22(1):29-34
pubmed: 11906616
Crit Care Med. 2006 Mar;34(3):625-31
pubmed: 16521260
Microbiol Immunol. 2006;50(12):1001-13
pubmed: 17179669
Br J Haematol. 2009 Apr;145(1):24-33
pubmed: 19222477
Eur J Immunol. 1991 Nov;21(11):2887-90
pubmed: 1936126
Thromb Res. 2010 Jan;125(1):6-11
pubmed: 19782389
Clin Infect Dis. 2009 Nov 1;49(9):1380-6
pubmed: 19793001
Crit Care. 2009;13(6):R176
pubmed: 19891773
Hum Immunol. 2010 Nov;71(11):1084-8
pubmed: 20732365
J Biol Chem. 1990 Jun 5;265(16):9072-6
pubmed: 2140568
J Biochem. 2012 Jan;151(1):57-64
pubmed: 21893516
Thromb Res. 2012 May;129(5):e177-84
pubmed: 21930293
J Biomed Biotechnol. 2012;2012:493945
pubmed: 22570530
J Thromb Haemost. 2013 Feb 4;:null
pubmed: 23379279
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
J Thromb Thrombolysis. 2014 Oct;38(3):331-8
pubmed: 24474086
J Infect Chemother. 2014 Mar;20(3):157-62
pubmed: 24530102
N Engl J Med. 2014 Feb 27;370(9):847-59
pubmed: 24571757
Thromb Res. 2014 May;133 Suppl 1:S28-31
pubmed: 24759136
Early Hum Dev. 2014 Oct;90(10):557-64
pubmed: 25105751
Inflammation. 2015 Feb;38(1):338-47
pubmed: 25323207
J Crit Care. 2015 Apr;30(2):290-5
pubmed: 25547047
Thromb Res. 2015 Aug;136(2):239-42
pubmed: 26033399
Immunobiology. 2016 Oct;221(10):1058-67
pubmed: 27377710
J Intensive Care. 2016 Jul 12;4:44
pubmed: 27413534
J Biol Chem. 1988 Dec 5;263(34):18205-12
pubmed: 2848029
Br J Haematol. 2018 Mar;180(6):782-798
pubmed: 29265338
J Exp Med. 1983 Aug 1;158(2):603-15
pubmed: 6604123
J Biochem. 1983 Sep;94(3):937-47
pubmed: 6643429
Biochem Biophys Res Commun. 1980 Jul 31;95(2):658-64
pubmed: 6774714
J Exp Med. 1993 Aug 1;178(2):579-87
pubmed: 7688027
J Exp Med. 1997 May 5;185(9):1619-27
pubmed: 9151899
Thromb Haemost. 1997 Feb;77(2):394-8
pubmed: 9157602

Auteurs

Mineji Hayakawa (M)

1 Emergency and Critical Care Center, Hokkaido University Hospital, Sapporo, Japan.

Katsuki Ohtani (K)

2 Department of Microbiology and Immunochemistry, Asahikawa Medical University, Asahikawa, Japan.
3 Department of Food and Human Wellness, Rakuno Gakuen University, Ebetsu, Japan.

Nobutaka Wakamiya (N)

2 Department of Microbiology and Immunochemistry, Asahikawa Medical University, Asahikawa, Japan.
3 Department of Food and Human Wellness, Rakuno Gakuen University, Ebetsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH